antidepressants

STAR*D Dethroned?

“Since 2006, STAR*D stands out as an icon guiding treatment decisions of major depressive disorder. But what if it is broken?“ This article by Dr. John J. Miller has been published in Psychiatric Times. It begins: “In the treatment of  major depressive disorder  (MDD),…
Read more

Mindfulness as Effective as Antidepressant for the Treatment of Anxiety Disorders

This report from Richard Sears has been published by Mad in America. It begins: “A new article published in JAMA Psychiatry finds that mindfulness based stress reduction (MBSR) is as effective in treating anxiety disorders as the antidepressant escitalopram. According to the current…
Read more

Experts call for fewer antidepressants to be prescribed in UK

“Open letter to government from experts and politicians says rising usage ‘is a clear example of over-medicalisation’” This report by Tobi Thomas has been published in The Guardian. It begins: “Medical experts and politicians have called for the amount of antidepressants…
Read more

The New WHO and UN Guidance: Psychiatry Must Entirely Change

“A fundamental shift is required within the field of mental health … There is an overreliance on biomedical approaches to treatment options, inpatient services and care, and little attention given to social determinants and community-based, person-centred interventions…” The new World…
Read more

Beyond the Chemical Imbalance Theory of Depression: An Interview with Prof. Joanna Moncrieff

This interview , conducted by Justin Garson, has been published in Psychology Today. It begins: “KEY POINTS In 2022, a large review led by Joanna Moncrieff showed the ‘serotonin theory of depression’ to be groundless. Her review puts into question our…
Read more

RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practice

The abstract for this research protocol (published by BMC) says: “Background Many people experience withdrawal symptoms when they attempt to stop antidepressants. Withdrawal symptoms are readily misconstrued for relapse or ongoing need for medication, contributing to long-term use (> 12 months). Long-term antidepressant use…
Read more

Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory

This research paper has been published in JAMA Psychiatry. Key Points: Question: Is intrauterine exposure to selective serotonin reuptake inhibitors (SSRIs) and prenatal or postnatal depressive symptoms associated with brain morphologic trajectory in offspring? Findings: In this cohort study of 3198 mother-infant…
Read more

Acceptability and optimisation of resources to support antidepressant cessation: A qualitative think-aloud study with patients

This study by Suzanne McDonald, Katharine Ann Wallis, Mark Horowitz, Esther Mann, Vilany Le and Maria Donald has been published in the British Journal of General Practice. The abstract says: “Background: Stopping long-term (>12 months) antidepressants can be difficult for patients…
Read more

Wishful thinking: antidepressant drugs in childhood depression

This paper from Anne Tonkin and Jon Jureidini has been published in the British Journal of Psychiatry. It begins: “The use of selective serotonin reuptake inhibitors (SSRIs) in children under 18 years old increased ten-fold (from 0.5 to 4.6 per 1000)…
Read more

Risk of Suicidal Behaviors and Antidepressant Exposure Among Children and Adolescents: A Meta-Analysis of Observational Studies

This meta-analysis has been published in the journal Frontiers in Psychiatry. The summary is as follows: “Objectives: Although several studies have reviewed the suicidal risk of antidepressants, the conclusions remain inconsistent. We, therefore, performed a meta-analysis of observational studies to address the…
Read more

Follow

Get the latest posts delivered to your mailbox:

Your email address will not be passed to any other organisation. It will only be used to send you new posts made on this website.

MENU